Overview

CKD-828 (80/5mg) Pharmacokinetic Study

Status:
Completed
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
A randomized, open-label, single-dose, four-period, two-way, crossover study,
Phase:
Phase 1
Details
Lead Sponsor:
Chong Kun Dang Pharmaceutical
Treatments:
Amlodipine
Telmisartan